{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:09:14Z","timestamp":1778843354053,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["SC1922"],"award-info":[{"award-number":["SC1922"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["BD-47"],"award-info":[{"award-number":["BD-47"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.preghy.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T11:54:49Z","timestamp":1660391689000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Intensive care patients with preeclampsia \u2013 Clinical risk factors and biomarkers for oxidative stress and angiogenic imbalance as discriminators for severe disease"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-7260","authenticated-orcid":false,"given":"Camilla","family":"Edvinsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4350-5909","authenticated-orcid":false,"given":"Lena","family":"Erlandsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan R","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.preghy.2022.08.005_b0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/AOG.0b013e318231934c","article-title":"Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications","volume":"118","author":"Al-Safi","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"17","key":"10.1016\/j.preghy.2022.08.005_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.preghy.2019.05.019","article-title":"Evi Katagis, Preeclampsia postpartum: impairment of cerebral autoregulation and reversible cerebral hyperperfusion","volume":"2019","author":"Janzarika","year":"2019","journal-title":"Pregnancy Hypertension"},{"issue":"2","key":"10.1016\/j.preghy.2022.08.005_b0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0889-8545(21)00184-4","article-title":"Complicated postpartum preeclampsia-eclampsia","volume":"22","author":"Magann","year":"1995","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.preghy.2022.08.005_b0020","doi-asserted-by":"crossref","unstructured":"Redman, C., Preeclampsia: A multi-stress disorder. La Revue de medecine interne 32 S (2011), 2011: p. 41-44.","DOI":"10.1016\/j.revmed.2011.03.331"},{"key":"10.1016\/j.preghy.2022.08.005_b0025","doi-asserted-by":"crossref","unstructured":"Redman CWG, M.M., Staff AC, Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am. J. Obstetr. Gynecol. 213(4) 2015 S9.e1-S9e4.","DOI":"10.1016\/j.ajog.2015.08.003"},{"key":"10.1016\/j.preghy.2022.08.005_b0030","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","author":"Redman","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.005_b0035","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1038\/s41598-017-04468-0","article-title":"Syncytiotrophoblast derived extracellular vesicles transfer functional placental miRNAs to primary human endothelial cells","volume":"7","author":"Cronqvist","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preghy.2022.08.005_b0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/HYPERTENSIONAHA.117.10182","article-title":"Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia","volume":"71","author":"Agrawal","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.005_b0045","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation","volume":"214","author":"O'Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.005_b0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.preghy.2022.08.005_b0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.preghy.2022.08.005_b0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.preghy.2022.08.005_b0065","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jog.14815","article-title":"sFlt-1\/PlGF ratio as a predictive and prognostic marker for preeclampsia","volume":"47","author":"Jeon","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.preghy.2022.08.005_b0070","doi-asserted-by":"crossref","unstructured":"U.D. Anderson, et al., Fetal hemoglobin and \u03b11-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia. Am. J. Obstet. Gynecol, 204(6) 2011 520.e1-5.","DOI":"10.1016\/j.ajog.2011.01.058"},{"issue":"9","key":"10.1016\/j.preghy.2022.08.005_b0075","doi-asserted-by":"crossref","first-page":"e0138111","DOI":"10.1371\/journal.pone.0138111","article-title":"The human endogenous protection system against cell-free Hemoglobin and Heme is overwhelmed in preeclampsia and provides potential biomarkers and clinical indicators","volume":"10","author":"Gram","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.preghy.2022.08.005_b0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.freeradbiomed.2009.10.052","article-title":"Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia","volume":"48","author":"Olsson","year":"2010","journal-title":"Free Radical Biol. Med."},{"issue":"7","key":"10.1016\/j.preghy.2022.08.005_b0085","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1182\/blood-2005-03-1185","article-title":"Identification of the receptor scavenging hemopexin-heme complexes","volume":"106","author":"Hvidberg","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.preghy.2022.08.005_b0090","doi-asserted-by":"crossref","first-page":"e0239030","DOI":"10.1371\/journal.pone.0239030","article-title":"Hemopexin and \u03b11-microglobulin heme scavengers with differential involvement in preeclampsia and fetal growth restriction","volume":"15","author":"Youssef","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preghy.2022.08.005_b0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.preghy.2018.02.005","article-title":"The hemoglobin degradation pathway in patients with preeclampsia - fetal hemoglobin, heme, hemeoxygenase-1 and hemopexin - potential diagnostic biomarkers?","volume":"14","author":"Anderson","year":"2018","journal-title":"Pregnancy Hypertens."},{"issue":"2","key":"10.1016\/j.preghy.2022.08.005_b0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.preghy.2016.02.003","article-title":"Fetal hemoglobin, \u03b11-microglobulin and hemopexin are potential predictive first trimester biomarkers for preeclampsia","volume":"6","author":"Anderson","year":"2016","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2022.08.005_b0105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2022.08.005_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fphys.2019.00300","article-title":"Plasma Heme Scavengers Alpha-1-Microglobulin and hemopexin as biomarkers in high-risk pregnancies","volume":"10","author":"Kalapotharakos","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.preghy.2022.08.005_b0115","doi-asserted-by":"crossref","unstructured":"SE, A., Is Use of Multiple Antihypertensive Agents to Achieve Blood Pressure Control Associated with Adverse Pregnancy Outcomes? J. Perinatol. 2017 April ; 37(4): 340\u2013344. , 2017.","DOI":"10.1038\/jp.2016.247"},{"issue":"68","key":"10.1016\/j.preghy.2022.08.005_b0120","first-page":"1153","article-title":"The CHIPS randomized controlled trial (control of hypertension in pregnancy study) is severe hypertension just an elevated blood pressure?","volume":"2016","author":"La","year":"2016","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.preghy.2022.08.005_b0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.preghy.2022.08.005_b0130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/HYPERTENSIONAHA.108.127951","article-title":"Vascular contraction and preeclampsia: downregulation of the Angiotensin receptor 1 by hemopexin in vitro","volume":"53","author":"Bakker","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2022.08.005_b0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2014.06.025","article-title":"A1M, an extravascular tissue cleaning and housekeeping protein","volume":"74","author":"\u00c5kerstr\u00f6m","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.preghy.2022.08.005_b0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2007.07.017","article-title":"Quantitative and qualitative evaluation of plasma and urine alpha1-microglobulin in healthy donors and patients with different haemolytic disorders and haemochromatosis","volume":"386","author":"Nordberg","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.preghy.2022.08.005_b0145","doi-asserted-by":"crossref","first-page":"8561","DOI":"10.1038\/s41598-019-44639-9","article-title":"Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model","volume":"9","author":"Erlandsson","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.preghy.2022.08.005_b0150","doi-asserted-by":"crossref","first-page":"e86353","DOI":"10.1371\/journal.pone.0086353","article-title":"A1M\/\u03b11-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia","volume":"9","author":"Wester-Rosenl\u00f6f","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.preghy.2022.08.005_b0155","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/uog.17547","article-title":"Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia","volume":"51","author":"Saleh","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2022.08.005_b0160","article-title":"The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia","author":"Stefan Verlohren","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2022.08.005_b0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preghy.2020.09.009","article-title":"Prediction of adverse maternal outcomes of early severe preeclampsia","volume":"22","author":"Mirkovic","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2022.08.005_b0170","doi-asserted-by":"crossref","unstructured":"S, R., Angiogenic Factors and the Risk of Adverse Outcomes in Women with Suspected Preeclampsia. Circulation. 2012 February 21; 125(7): 911\u2013919., 2012.","DOI":"10.1161\/CIRCULATIONAHA.111.054361"},{"issue":"11","key":"10.1016\/j.preghy.2022.08.005_b0175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/pd.4432","article-title":"The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia","volume":"34","author":"Pinheiro","year":"2014","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.preghy.2022.08.005_b0180","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/HYPERTENSIONAHA.118.12205","article-title":"Angiogenic factor estimation as a warning sign of preeclampsia-related peripartum morbidity among hospitalized patients","volume":"73","author":"Perdigao","year":"2019","journal-title":"Hypertension"},{"issue":"39","key":"10.1016\/j.preghy.2022.08.005_b0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/10641955.2020.1800030","article-title":"Hypothyroidism and the increased risk of preeclampsia - interpretative factors?","volume":"4","author":"Lintula","year":"2020","journal-title":"Hypertens. Pregnancy"},{"issue":"3","key":"10.1016\/j.preghy.2022.08.005_b0190","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/10641955.2020.1765174","article-title":"Fetal gender, serum human chorionic gonadotropin, and testosterone in women with preeclampsia","volume":"39","author":"Ibrahim","year":"2020","journal-title":"Hypertens. Pregnancy"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778922000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778922000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:26:12Z","timestamp":1778840772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778922000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":38,"alternative-id":["S2210778922000873"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2022.08.005","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive care patients with preeclampsia \u2013 Clinical risk factors and biomarkers for oxidative stress and angiogenic imbalance as discriminators for severe disease","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}]}}